Home

Stacy Ann Coen

CIK 1814150 · SVP & CHIEF BUSINESS OFFICER · last filed 2025-06-12

Stacy Ann Coen is a SVP & CHIEF BUSINESS OFFICER who has filed 28 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for FBLG, was dated Jun 12, 2025. Across all open-market trades the lifetime net is −$4.9M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$4.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FBLG Director — $0.65 — $0 2 2025-06-12
ImmunoGen, Inc. (IMGN) Delisted SVP & CHIEF BUSINESS OFFICER 0 $31.23 $0 -$4.86M 18 2024-02-12

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-12 FBLG Grant (A) — $0 EDGAR
2024-08-27 FBLG Grant (A) — $0 EDGAR
2024-02-12 ImmunoGen, Inc. (IMGN) Delisted Disp (D) −73,274 $0 EDGAR
2024-02-06 ImmunoGen, Inc. (IMGN) Delisted Mixed +9,767 -$134.3K EDGAR
2024-02-05 — Notice (144) −4,583 -$134.3K EDGAR
2024-02-05 ImmunoGen, Inc. (IMGN) Delisted Grant (A) — $0 EDGAR
2024-01-03 ImmunoGen, Inc. (IMGN) Delisted Mixed +30,367 $165.5K EDGAR
2023-12-05 ImmunoGen, Inc. (IMGN) Delisted Sell (S) −3,826 -$111.7K EDGAR
2023-12-01 — Notice (144) −3,826 -$111.7K EDGAR
2023-11-17 — Notice (144) −78,223 -$1.26M EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.